Distant metastasis of gastric cancer is associated with elevated expression of the antimetastatic nm23 gene

Cancer Letters

Volumn 128, Issue 1, 1998, Pages 23-29

  Wang, Chia Siu ^a   Lin, Kwang Huei ^a   Hsu, Yu Chun ^a   Hsueh, Swei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Distant metastasis; Gastric cancer; Lymph node metastasis; nm23 gene; Nm23 H1 protein; Western blot analysis

Indexed keywords

PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SIGNET RING CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM METASTASIS; NUCLEOSIDE-DIPHOSPHATE KINASE; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0032486454     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00043-3     Document Type: Article

References (24)

1. Steeg P.-S., Bevilacqua G., Kopper I., Thorgerisson U.-P., Talmadage J.-E., Liotta L.-A.et al. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 80:1988;200-204.
2. De La Rosa A., Williams R.-L., Steeg P.-S. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays. 17:1995;53-62.
3. Stahl J.-A., Leone A., Rosengard A.-M., Porter L., King C.-R., Steeg P.-S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 51:1991;445-449.
4. Tokunaga Y., Urano T., Furukawa K., Kondo H., Kanematsu T., Shiku H. Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymph node metastasis of human breast cancer. Int. J. Cancer. 55:1993;66-71.
5. Hailat N., Keim D.-R., Melhem R.-F., Zhu X.-X., Eckerskorn C., Brodeur G.-M.et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with n-myc gene amplification. J. Clin. Invest. 88:1991;341-345.
6. Shina H., Igawa M., Urakami S., Shirakawa H., Ishibe T. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder. Br. J. Urol. 76:1995;708-713.
7. Myeroff L.-L., Markowitz S.-D. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J. Natl. Cancer Inst. 85:1993;147-152.
8. Wang L., Patel U., Ghosh L., Chen H.-C., Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res. 53:1993;717-720.
9. Nakayama H., Yasui W., Yokozaki H., Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinoma. Jpn. J. Cancer Res. 84:1993;184-190.
10. Kodera Y., Isobe K., Yamauchi M., Kondoh K., Kimura N., Akiyama S., Itoh K., Nakashima I. Expression of nm23 H-1 RNA levels in human gastric cancer tissues. Cancer. 15:1994;259-265.
11. Ura H., Denno R., Hirata K. The significance of nm23 protein expression in human gastric cancer. Surg. Today. 26:1996;957-965.
12. Zhang S., Ye S., Lin H. Gastric cancer with p53 overexpression and nm23 low-expression has high potential for lymph node metastasis. Chung Hua Chung Liu Tsa Chih. 17:1995;418-421.
13. Japanese Research Society for Gastric Cancer, The General Rules for the Gastric Cancer Study in Surgery and Pathology, twelfth ed., Kanehara, Tokyo, 1993.
14. UICC International Union Against Cancer, TNM Classification of Malignant Tumors, fourth ed., UICC, Geneva, 1987.
15. Bradford M.-M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
16. M.-H. Huh, Y.-O. Kim, H.-K. Chang, An immunohistochemical study of correlation of plasminogen activator inhibitor-1 and nm23 and lymph node metastasis in gastric adenocarcinoma, in: J.R. Siewert, J.D. Roder (Eds.), Progress in Gastric Cancer Research, Monduzzi Editore, Bologna, 1997, pp. 451-456.
17. S.-K. Song, S.-W. Kim, M.-C. Shim, K.-B. Kwun, The clinical significance of nm23 and plasminogen activator inhibitor-1 (PAI-1) in gastric cancer, in: J.R. Siewert, J.D. Roder (Eds.), Progress in Gastric Cancer Research, Monduzzi Editore, Bologna, 1997, pp. 457-460.
18. H.-J. Yu, Expression of p53, nm23, and c-erbB-2 in gastric cancer, in: J.R. Siewert, J.D. Roder (Eds.), Progress in Gastric Cancer Research, Monduzzi Editore, Bologna, 1997, pp. 521-526.
19. K.-C. Kroening, L.-M. Pernice, S. Catarzi, A. Amorosi, M. Paglerani, D. Pantalone, F. Renzi, P. Prosperi, Relationship between Nm23 expression and human gastric cancer both stage and survival, in: J.R. Siewert, J.D. Roder (Eds.), Progress in Gastric Cancer Research, Monduzzi Editore, Bologna, 1997, pp. 689-694.
20. W. Mueller, A. Schneiders, G. Hommel, H.-E. Gabbert, Prognostic value of the putative metastasis suppressor gene nm23 in gastric cancer, in: J.R. Siewert, J.D. Roder (Eds.), Progress in Gastric Cancer Research, Monduzzi Editore, Bologna, 1997, pp. 701-706.
21. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119:1993;265-272.
22. Srivatsa P.J., Cliby W.A., Keeney G.L., Dodson M.K., Suman V.J., Roche P.C., Podratz K.C. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol. Oncol. 60:1996;363-372.
23. Igawa M., Urakami S., Shiina H., Ishibe T., Usui T., Chodak G.W. Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy. Eur. Urol. 30:1996;383-387.
24. Livingstone J.-I., Yasui W., Tahara E., Wastell C. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br. J. Cancer. 72:1995;976-980.